Lazard Asset Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-25,647
| Closed | -$2.55M | – | 1737 |
|
|
2019
Q3 | $2.55M | Hold |
25,647
| – | – | ﹤0.01% | 637 |
|
|
2019
Q2 | $2.37M | Buy |
+25,647
| New | +$2.44M | ﹤0.01% | 737 |
|
|
2019
Q1 | – | Sell |
-141,337
| Closed | -$9.06M | – | 1239 |
|
|
2018
Q4 | $9.06M | Sell |
141,337
-39,526
| -22% | -$2.92M | 0.02% | 427 |
|
|
2018
Q3 | $16.2M | Buy |
180,863
+21,697
| +14% | +$1.92M | 0.03% | 341 |
|
|
2018
Q2 | $12.6M | Sell |
159,166
-217,591
| -58% | -$18.1M | 0.02% | 383 |
|
|
2018
Q1 | $33.6M | Sell |
376,757
-13,609
| -3% | -$1.31M | 0.06% | 215 |
|
|
2017
Q4 | $40.7M | Sell |
390,366
-1,277,079
| -77% | -$144M | 0.07% | 196 |
|
|
2017
Q3 | $243M | Buy |
1,667,445
+156,471
| +10% | +$21.3M | 0.44% | 58 |
|
|
2017
Q2 | $196M | Buy |
1,510,974
+457,563
| +43% | +$56.1M | 0.37% | 67 |
|
|
2017
Q1 | $131M | Sell |
1,053,411
-34,372
| -3% | -$4.11M | 0.25% | 79 |
|
|
2016
Q4 | $126M | Sell |
1,087,783
-127,910
| -11% | -$14.2M | 0.26% | 80 |
|
|
2016
Q3 | $127M | Sell |
1,215,693
-85,401
| -7% | -$9.24M | 0.25% | 83 |
|
|
2016
Q2 | $128M | Buy |
1,301,094
+1,247,397
| +2,323% | +$129M | 0.27% | 86 |
|
|
2016
Q1 | $5.37M | Sell |
53,697
-25,921
| -33% | -$2.67M | 0.01% | 486 |
|
|
2015
Q4 | $9.53M | Sell |
79,618
-61,360
| -44% | -$7.1M | 0.02% | 405 |
|
|
2015
Q3 | $15.2M | Buy |
140,978
+5,369
| +4% | +$666K | 0.04% | 280 |
|
|
2015
Q2 | $15.7M | Buy |
135,609
+25,726
| +23% | +$2.94M | 0.03% | 295 |
|
|
2015
Q1 | $12.7M | Buy |
109,883
+7,895
| +8% | +$943K | 0.03% | 326 |
|
|
2014
Q4 | $11.4M | Sell |
101,988
-27,694
| -21% | -$2.92M | 0.02% | 374 |
|
|
2014
Q3 | $12.3M | Buy |
129,682
+1,258
| +1% | +$114K | 0.03% | 335 |
|
|
2014
Q2 | $11M | Buy |
128,424
+1,008
| +0.8% | +$76.7K | 0.02% | 377 |
|
|
2014
Q1 | $8.89M | Buy |
127,416
+36
| +0% | +$2.85K | 0.02% | 394 |
|
|
2013
Q4 | $10.8M | Sell |
127,380
-28,232
| -18% | -$2.23M | 0.02% | 351 |
|
|
2013
Q3 | $12M | Buy |
155,612
+6,054
| +4% | +$424K | 0.03% | 322 |
|
|
2013
Q2 | $8.74M | Buy |
+149,558
| New | +$9M | 0.02% | 393 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Lazard Asset Management's CELG Position: Q4 2019 in Review
Lazard Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 25,647 shares — an estimated $2.55M sold.
Lazard Asset Management first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $243M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Lazard Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Lazard Asset Management sold 25,647 Celgene Corp shares in Q4 2019, an estimated $2.55M.
- Lazard Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
- Lazard Asset Management's Celgene Corp position peaked at $243M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.